Arthur Kavanaugh Selected Research

Arthur Kavanaugh Research Topics

Disease

106	Psoriatic Arthritis 02/2024 - 04/2005
94	Rheumatoid Arthritis 03/2024 - 02/2002
43	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 04/2005
24	Pain (Aches) 03/2024 - 02/2004
24	Arthritis (Polyarthritis) 02/2024 - 04/2005
18	Necrosis 02/2024 - 10/2003
17	Ankylosing Spondylitis 09/2022 - 07/2006
16	Inflammation (Inflammations) 03/2024 - 07/2008
14	Fatigue 12/2022 - 02/2004
14	Infections 01/2022 - 05/2004
9	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 10/2005
7	Joint Diseases (Joint Disease) 02/2024 - 09/2013
6	Neoplasms (Cancer) 01/2022 - 07/2008
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 10/2002
6	Disease Progression 09/2019 - 03/2006
5	Tuberculosis (Tuberculoses) 01/2022 - 05/2004
5	Chronic Disease (Chronic Diseases) 01/2021 - 12/2015
5	Rheumatic Diseases (Rheumatism) 01/2018 - 02/2006
4	Synovitis 03/2024 - 02/2011
4	Spondylitis 08/2023 - 12/2008
4	Crohn Disease (Crohn's Disease) 01/2023 - 11/2007
4	Skin Diseases (Skin Disease) 12/2022 - 01/2008
4	Gout 01/2017 - 03/2006
3	Opportunistic Infections (Opportunistic Infection) 01/2022 - 03/2015
3	Respiratory Tract Infections (Respiratory Tract Infection) 08/2020 - 09/2015
3	Nasopharyngitis 08/2020 - 09/2015
2	Axial Spondyloarthritis 08/2023 - 01/2023
2	Ulcerative Colitis 01/2023 - 01/2018
2	Nail Diseases (Nail Disease) 01/2022 - 04/2009
2	Headache (Headaches) 08/2020 - 10/2016
2	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2020 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2018
2	Candidiasis (Moniliasis) 01/2020 - 01/2018
2	Lymphoma (Lymphomas) 11/2017 - 03/2015

Drug/Important Bio-Agent (IBA)

32	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 10/2002
29	Adalimumab (Humira)FDA Link 03/2024 - 07/2006
22	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 05/2004
22	golimumab FDA Link 01/2022 - 04/2009
20	Antirheumatic Agents (DMARD)IBA 02/2024 - 10/2003
18	C-Reactive ProteinIBA 03/2024 - 02/2011
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2020 - 06/2002
14	ametantrone (HAQ)IBA 02/2024 - 02/2004
14	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 02/2009
11	apremilastIBA 01/2022 - 01/2014
10	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2007
10	Infliximab (Remicade)FDA Link 08/2013 - 06/2002
9	Interleukin-17 (Interleukin 17)IBA 02/2024 - 02/2014
9	Monoclonal AntibodiesIBA 12/2022 - 02/2009
9	secukinumabIBA 01/2022 - 09/2015
8	Etanercept (Enbrel)FDA Link 01/2023 - 07/2006
8	tofacitinibIBA 01/2022 - 01/2014
7	LipidsIBA 03/2024 - 10/2002
7	Rituximab (Mabthera)FDA Link 01/2016 - 09/2003
6	guselkumabIBA 02/2024 - 01/2021
6	InterleukinsIBA 02/2024 - 02/2009
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2003
6	Interleukin-12 (IL 12)IBA 01/2023 - 02/2009
6	CytokinesIBA 01/2023 - 02/2002
6	Certolizumab Pegol FDA Link 01/2020 - 01/2009
6	Interleukin-6 (Interleukin 6)IBA 10/2016 - 01/2003
5	Syk KinaseIBA 12/2014 - 11/2008
4	OxylipinsIBA 03/2024 - 01/2021
4	GLPG0634IBA 03/2024 - 01/2018
4	ixekizumabIBA 02/2024 - 07/2019
4	Prostaglandins AIBA 12/2023 - 09/2009
4	AntibodiesIBA 08/2022 - 03/2014
4	AntigensIBA 01/2020 - 03/2003
4	fostamatinibIBA 12/2014 - 02/2011
4	GlucocorticoidsIBA 10/2014 - 10/2003
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2023 - 01/2020
3	Interleukin-23 (Interleukin 23)IBA 12/2022 - 06/2014
3	Janus Kinase InhibitorsIBA 01/2022 - 12/2018
3	Rheumatoid FactorIBA 12/2021 - 05/2007
3	AutoantibodiesIBA 01/2018 - 02/2006
3	Phosphodiesterase 4 InhibitorsIBA 01/2018 - 06/2014
3	Uric Acid (Urate)IBA 01/2016 - 03/2006
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2004
3	Immunoglobulins (Immunoglobulin)IBA 10/2010 - 12/2007
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2006 - 09/2003
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2024 - 01/2021
2	upadacitinibIBA 01/2023 - 08/2022
2	bimekizumabIBA 12/2022 - 01/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2011
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 03/2021
2	Anti-Citrullinated Protein AntibodiesIBA 12/2021 - 01/2008
2	cyclic citrullinated peptideIBA 12/2021 - 01/2008
2	Leflunomide (Arava)FDA LinkGeneric 06/2020 - 08/2004
2	Antiphospholipid AntibodiesIBA 01/2020 - 01/2020
2	amsonic acid (DAS)IBA 05/2019 - 01/2019
2	Biosimilar PharmaceuticalsIBA 01/2019 - 01/2018
2	GP2015IBA 01/2019 - 01/2018
2	EpitopesIBA 01/2018 - 11/2009
2	SteroidsIBA 01/2018 - 02/2011

Therapy/Procedure

74	Therapeutics 03/2024 - 02/2002
8	Biological Therapy 01/2018 - 07/2007
3	Subcutaneous Injections 01/2020 - 04/2009
2	Contraception (Birth Control) 01/2020 - 01/2020
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020 - 01/2020
2	Excimer Lasers 09/2019 - 01/2012
2	Aftercare (After-Treatment) 11/2018 - 10/2016